You may also like
Page 26 of 28
In this episode of the Focus on Eye Health Podcast, host Christopher Hord talks with Michael Lehmicke of the Alliance for Regenerative Medicine (ARM). Michael explains how cutting-edge cell and gene therapies are transforming treatment options for conditions like age-related macular degeneration (AMD), retinitis pigmentosa, Stargardt disease, and other vision disorders. Learn about current clinical trials, FDA-approved therapies, and what the future may hold for people living with blindness and low vision.
This episode is sponsored by BlueRock Therapeutics.